Home » Green Cross Files for Peramivir Regulatory Approval in South Korea
Green Cross Files for Peramivir Regulatory Approval in South Korea
BioCryst Pharmaceuticals, Inc. announced that it has been informed by its partner, Green Cross Corp., that Green Cross has filed a New Drug Application
in South Korea to seek regulatory approval for intravenous peramivir to treat patients with influenza.
SunHerald
SunHerald
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May